Teradyne CEO sells 1,108 shares under Rule 10b5-1 plan
Teradyne, Inc.'s President and CEO, who is also a director, reported a sale of common stock.
Rhea-AI Filing Summary
Teradyne, Inc.'s President and CEO, who is also a director, reported a sale of common stock. On December 12, 2025, the insider sold 1,108 shares of Teradyne common stock at $ 201.31 per share, coded as a sale transaction.
The shares were sold pursuant to a sales plan adopted by the reporting person on February 4, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. After this transaction, the insider beneficially owned 93,408.995 shares of Teradyne common stock, held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,108 | $201.31 | $223K |
Footnotes (1)
- F1. The shares were sold pursuant to a sales plan adopted by the Reporting Person on February 4, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
FAQ
What insider transaction in Teradyne (TER) stock was reported?
The filing reports that Teradyne's President and CEO, who is also a director, sold 1,108 shares of Teradyne common stock on December 12, 2025.
Was the Teradyne (TER) stock sale made under a Rule 10b5-1 plan?
Yes. The shares were sold pursuant to a sales plan adopted on February 4, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
Is this Teradyne (TER) Form 4 filed by one or multiple reporting persons?
The document indicates that the Form 4 was filed by one reporting person, not by a group.
AI-generated analysis. How Rhea-AI works. Not financial advice.